Introduction
============

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood at a prevalence rate of 1 in 1000, and JIA is a common cause of disability among children ([@B39]). The typical clinical manifestation of JIA is joint enlargement of unknown origin for more than 6 weeks in children under 16 years old ([@B44]). JIA has long been considered as a type of autoimmune disease, however, its etiology is still not fully understood. Similar to other complex diseases, genetic and environmental factors both contribute to its pathogenesis ([@B17]). Substantial evidence suggests the large contribution of genetic components. Previous studies showed that monozygotic twin concordance rates for JIA are between 25 and 40%, much higher than the population prevalence rate ([@B48]). Affected sibling studies showed that siblings of JIA probands had an over 10-fold increased risk of developing the disease ([@B15]). Our recent heritability study based on SNP-h2 estimated that the heritability of JIA is 0.73 among the most highly heritable pediatric autoimmune diseases ([@B32]). Several genome-wide association studies (GWAS) have been carried out and discovered a number of JIA susceptibility loci, but how these loci affect the pathogenesis and development of JIA remains to be explored ([@B4]; [@B21], [@B22]; [@B56]; [@B7]; [@B2]; [@B31]; [@B12]; [@B40]; [@B18]).

Neutrophils are one of the most important innate immune cells in human bodies. When infection or inflammation occurs, they are recruited to the disease site under the attraction of chemokines. In recent years, studies have found that neutrophils can secrete a variety of cytokines to play a key role in immunomodulation. The clinical manifestations of JIA are highly similar to those of classical autoinflammatory diseases. The large accumulation of white blood cells is one of the causes for local tissue damage and loss of joint function due to the inflammatory response at the joint ([@B11]). Neutrophils likely play an important role in the effector phase of autoimmune diseases including JIA, and their action can cause or exacerbate articular inflammation ([@B38]). Neutrophil extracellular traps (NETs) are the newly discovered mechanism by which neutrophils fight infection, and has been demonstrated to play a role in pathogenesis of systemic immune diseases such as systemic lupus erythematosus (SLE) ([@B19]), antineutrophil cytoplasmic antibodies (ANCA)-associated systemic vasculitis ([@B29]) and multiple sclerosis ([@B37]). However, little is known about the genes involved in JIA development in neutrophils.

A number of JIA loci have been identified in GWAS ([@B4]; [@B21], [@B22]; [@B56]; [@B7]; [@B2]; [@B31]; [@B12]; [@B40]; [@B18]), but few have been functionally characterized as most of the GWAS SNPs are located at the intronic or intergenic regions, without directly affecting the sequence of any protein product. We hypothesize that they may function as *cis-*regulatory elements, regulating target gene expression. Therefore, we focused on understanding the target genes of JIA GWAS loci in neutrophils.

JIA is a heterogeneous group of diseases including several different subtypes. In recent years, due to the progress in disease management, their prognosis has been greatly improved, but there are still few effective treatments. Our study took an *in silico* analysis approach, utilizing genomics, transcriptome, epigenome, and methylome data to find genes targeted by JIA risk loci in neutrophils, facilitating the design of precision strategy of JIA prevention and treatment.

Materials and Methods {#s1}
=====================

Extraction of JIA GWAS Loci
---------------------------

Juvenile idiopathic arthritis loci identified in previous GWAS were found in GWAS catalog ([@B35]) by conducting search using keyword "Juvenile idiopathic arthritis." All loci found were downloaded without further imposing any significance threshold.

eQTL Analysis
-------------

eQTL analysis was performed via Genotype-Tissue Expression (GTEx) Project website ([@B34]), from which the correlation between each SNP genotype and gene expression level in whole blood was extracted. We set the significance threshold as *P*-value \< 0.05. The boxplots for the SNP-gene pairs were reviewed via GTEx Portal.

Analysis of Microarray Data
---------------------------

Series matrix files of microarray datasets GSE11083 ([@B13],[@B14]) and GSE67596 ([@B26]) containing transcriptome data from neutrophils of 36 JIA patients and 26 healthy controls were downloaded from NCBI Gene Expression Omnibus (GEO) ([@B10]; [@B3]). Gene expression levels were compared between JIA patient group and control group. Expression values across studies was summarized through median polish and normalization was performed using Robust Multi-array Average (RMA) algorithm which minimizes variance across arrays and log transformation was conducted for variance stabilization ([@B25]). Meta-analysis were performed using RankProd package ([@B23]) in R 3.5.1 ([@B46]). The threshold used to select for differentially expressed genes was defined as possibility of false positives (PFP) \< 0.05 and absolute value of fold change (FC) \> 1.2.

Histone Modification Analysis
-----------------------------

The SNPs of interest were input into web portal Haploreg^[1](#fn01){ref-type="fn"}^ ([@B60]) and their overlap with histone modification regions in neutrophil cell line E030 BLD.CD15.PC (primary neutrophils from peripheral blood) was evaluated using epigenome data from ROADMAP epigenomics database ([@B30]).

Methylation Data Analysis
-------------------------

The methylation data were extracted from the genome-wide methylation profiles of 843 subjects processed on the Infinium HumanMethylation450 BeadChip at the Center for Applied Genomics, the Children's Hospital of Philadelphia, which has been described in previous publication ([@B57]). The log2 ratio between the methylated and unmethylated intensities of each probe on the chip was represented by the *M*-values. The association between JIA SNP genotype and methylation probes in each of the 11 genes was assessed in a linear regression model conditioned on gender, age and 10 genotype-derived principle components.

Construction of Protein-Protein Interaction (PPI) Network
---------------------------------------------------------

Protein-Protein Interaction network on the 11 target genes was constructed via NetworkAnalyst^[2](#fn02){ref-type="fn"}^ ([@B62]) which was based on integration of machine learning and Walktrap algorithms ([@B45]). The resource of protein-protein interaction data was IMEx Interactome database ([@B42]). Hypergeometric test for gene set enrichment analysis was implemented in NetworkAnalyst and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database ([@B27]) was used as the pathway database resource. In addition to FDR *P*-value calculated based on hypergeometric test and multiple-testing adjustment, empirical *P*-value of pathways was derived from permutation analysis. A list of 11 genes was randomly generated from the human genome and such resampling was performed 100 times. For each 11-gene list randomly drawn, the steps of network construction, pathway analysis were similarly performed as for JIA target genes in neutrophils, and a list of significantly enriched pathways with FDR \< 0.05 was resulted from each resampling. For each enriched pathway in PPI network of JIA target genes, its empirical *P*-value was derived based on the number of times it appears as significantly enriched pathway from 100 permutations.

Hi-C Data Visualization
-----------------------

Hi-C data visualization for the JIA loci and target genes were carried out via the 3D Genome browser^[3](#fn03){ref-type="fn"}^ ([@B59]) and FUMA GWAS^[4](#fn04){ref-type="fn"}^ ([@B61]). Hi-C data from cell line K562 ([@B47]; [@B49]) were used.

Results
=======

A large number of GWAS loci have been identified for human complex diseases, including JIA. We extracted all 127 genomic regions that have been reported to be associated with JIA from GWAS catalog ([@B4]; [@B21], [@B22]; [@B56]; [@B7]; [@B2]; [@B31]; [@B12]; [@B35]; [@B40]; [@B18]). All these SNPs are located outside of gene exons, which may contribute to disease etiology by affecting gene expression. We then input these SNPs into GTEx database ([@B34]) to identify genes that are regulated by these SNPs. Because GWAS SNPs and their target genes may not always exhibit highly significant correlation in eQTL analysis, exemplified by obesity SNP rs9930506 and IRX3 gene ([@B50]), we set the significance threshold as nominal *P*-value \< 0.05. We found that the expression level of 238 genes correlates with JIA SNP genotype in whole blood.

As we are particularly interested in identifying genes regulated by JIA GWAS loci in neutrophils, we examined which of these 238 genes showed differential expression in neutrophils between JIA cases and controls. We extracted two microarray datasets from gene expression omnibus (GEO) database, GSE11083 ([@B13],[@B14]) and GSE67596 ([@B26]). Gene expression data from a total of 36 JIA cases and 26 controls were meta-analyzed. Among the 264 eQTL genes for JIA SNPs, only 11 genes showed significant differential expression, including 5 up-regulated and 6 down-regulated ([Table 1](#T1){ref-type="table"}). Our *in silico* analysis suggested that these genes may function as JIA loci targeted genes in neutrophils. Among the 13 pairs of JIA SNPs and target genes, only SNP rs79893749 is located in the intron of its target gene *CCR3*; all the other SNPs are located outside of the transcript region of their target genes. Hi-C data provide additional supporting evidence for plausible chromatin interactions between some JIA SNPs and their target genes ([Supplementary Figures 1](#SM1){ref-type="supplementary-material"}, [2](#SM1){ref-type="supplementary-material"}), with the caveat that these data came from a chronic myelogenous leukemia cell line K562 ([@B47]; [@B49]). Experiments using neutrophils would be necessary to further explore their possible interactions.

###### 

Summary of JIA GWAS loci targeted genes in neutrophils.

                                                                             DEG                Methylation                            
  ------------- ---- ----------- ------------ -------- ----------- --------- ---------- ------- ------------------------- ------------ --------------
  rs4648881     1    25197155    *MTFR1L*     5^′^     5.E-07      4.0E-03   2.33E-02   -1.30   none                                   
                                                                                                                                       
                                                                                                                                       
  rs9633402     1    247946160   *TRIM58*     5^′^     3.E-06      5.4E-04   1.15E-02   1.21    none                      cg12689806   8.45E-02
                                                                                                                                       
                                                                                                                                       
  rs79893749    3    46253650    *CCR3*       intron   2.E-07      2.5E-04   1.68E-02   -1.27   H3K4me1_Enh               cg04111761   7.78E-03
                                                                                                                                       
                                                                                                                                       
  rs4869313     5    96223880    *ELL2*       5^′^     9.E-08      2.4E-02   4.04E-02   -1.26   none                                   
                                                                                                                                       
                                                                                                                                       
  rs41291794    6    32425762    *HLA-DPA1*   3^′^     ^∗^4.E-15   1.4E-02   8.20E-04   1.33    none                      cg13906813   1.64E-02
                                                                                                                                       
                                                                                                                                       
  rs7069750     10   90762376    *ACTA2*      5^′^     ^∗^3.E-08   4.9E-20   3.60E-03   1.27    none                      cg03111039   ^∗∗^6.52E-08
                                                                                                                                       
                                                                                                                                       
  rs7069750     10   90762376    *ANKRD22*    5^′^     ^∗^3.E-08   4.0E-03   3.64E-02   1.21    none                      cg15103050   1.52E-01
                                                                                                                                       
                                                                                                                                       
  rs12598357    16   28340945    *SH2B1*      5^′^     ^∗^4.E-09   4.4E-06   3.83E-04   1.68    none                      cg07884168   1.55E-02
                                                                                                                                       
                                                                                                                                       
  rs12598357    16   28340945    *SULT1A1*    3^′^     ^∗^4.E-09   9.6E-07   5.51E-03   -1.31   none                      cg09685060   ^∗∗^1.41E-09
                                                                                                                                       
                                                                                                                                       
  rs12928404    16   28847246    *SH2B1*      5^′^     6.E-07      1.9E-04   3.83E-04   1.68    none                      cg06932837   ^∗∗^5.13E-05
                                                                                                                                       
                                                                                                                                       
  rs12928404    16   28847246    *SULT1A1*    5^′^     6.E-07      5.0E-06   5.51E-03   -1.31   none                      cg26603685   ^∗∗^1.72E-07
                                                                                                                                       
                                                                                                                                       
  rs2847293     18   12782448    *MPPE1*      5^′^     ^∗^1.E-12   3.9E-02   2.01E-02   -1.36   none                      cg14599440   2.01E-03
                                                                                                                                       
                                                                                                                                       
  rs149850873   18   12885120    *CEP192*     5^′^     5.E-07      6.0E-03   4.90E-03   -1.37   H3K4me1_Enh H3K4me3_Pro   cg00686761   1.78E-01
                                                                                                                                       

SNP = single nucleotide polymorphism; Chr = chromosome; Pos (hg19) = position on human genome build hg19; Gene = likely targeted gene at each GWAS locus; Location = The SNP is located within intron, 5

′

upstream or 3

′

downstream of its target gene. GWAS_Pval =

P

-value of each SNP in GWAS analyses extracted from GWAS catalog; GTEx_Pval =

P

-value of correlation between gene expression level and GWAS SNP genotype in GTEx database; DEG_PFP = the probability of being false positive for the differentially expressed gene in the microarray analysis; DEG_FC = fold change of the differentially expressed gene in a microarray analysis; Histone Mark = histone marks overlap with each SNP in cell line E030 BLD.CD15.PC; Methylation_probe = the methylation probe with the minimum

P

-value in the target gene for association testing with the GWAS SNP; Methylation_Pval = the

P

-value of the methylation probe in methylation analysis;

∗

GWAS_Pval \< 5.E-08;

∗∗

Methylation

P

-value \< 3.5E-04; none = no histone modification was found in cell line E030 BLD.CD15.PC.

To understand how these genes coordinately contribute to JIA development, we constructed PPI network among proteins encoded by these genes and their direct interactors ([Figure 1](#F1){ref-type="fig"}) using NetworkAnalyst which integrates statistical analyses and machine learning for interactive PPI network visualization. We further conducted pathway analysis and found several signaling pathways significantly enriched among proteins in this network, including neurotrophin signaling pathway, cardiac muscle contraction, cell cycle and hypertrophic cardiomyopathy (HCM) ([Table 2](#T2){ref-type="table"}). To test the cell type specificity of 11 target genes and enriched pathways, we repeated the whole process using microarray gene expression data from PBMC samples of the same GEO datasets. We found that among the 11 target genes in neutrophils, one gene (TRIM58) was shared with PBMC ([Table 1](#T1){ref-type="table"} and [Supplementary Table 1](#SM1){ref-type="supplementary-material"}). No enriched pathway was shared between neutrophils and PBMC ([Figure 1](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}, [Supplementary Figure 3](#SM1){ref-type="supplementary-material"}, and [Supplementary Table 2](#SM1){ref-type="supplementary-material"}). To further determine the specificity of the 4 enriched pathways among JIA target genes in neutrophils, we checked the distribution of significantly enriched pathways from 100 randomly generated 11-gene lists and derived the empirical *P*-values for each of the 4 pathways of interest ([Table 2](#T2){ref-type="table"}). The pathways of cardiac muscle contraction and hypertrophic cardiomyopathy were of empirical *P*-value \< 0.01. Based on these two control gene set analyses, we demonstrated the specificity of these target genes and pathways in neutrophils, serving the initial screening purpose for further functional validation.

![PPI network of first-order interactions constructed for JIA loci target genes in neutrophils.](fgene-10-00181-g001){#F1}

###### 

KEGG pathways enriched among the PPI network formed by JIA loci target gene and their interactors (FDR \< 0.05).

  Pathway                          Total   Expected   Hits   *P*-value   FDR        Empirical *P*-value
  -------------------------------- ------- ---------- ------ ----------- ---------- ---------------------
  Neurotrophin signaling pathway   123     1.34       10     5.60E-07    1.21E-04   0.1
  Cardiac muscle contraction       12      0.131      4      5.81E-06    6.30E-04   \<0.01^∗^
  Cell cycle                       124     1.35       8      4.74E-05    3.43E-03   0.14
  Hypertrophic cardiomyopathy      25      0.272      4      1.34E-04    7.25E-03   \<0.01^∗^
                                                                                    

Total = the total number of genes in each pathway; Expected = the expected number of genes in each pathway given the number of JIA target genes; Hits = the actual number of JIA target genes falling into each pathway;

P

-value =

P

-value of each pathway in enrichment test; FDR = false discovery rate of each pathway;

∗

empirical

P

-value \< 0.01 based on permutation analysis.

Next, we investigated how JIA loci may regulate the expression of their targeted genes. To address this question, we examined the ROADMAP database ([@B30]) through HaploReg ([@B60]). We found rs79893749 and rs149850873 overlap with histone marks in a neutrophil cell line E030 BLD.CD15.PC, suggesting that these loci may regulate their targeted gene expression through histone modifications in the promoter or enhancer region. We also looked into the potential mechanism of DNA methylation. In our methylation analysis, we tested the 10 JIA SNPs against their corresponding one or two genes which each contains ∼11 methylation probes on average. A total of 144 SNP-methylation-probe pairs were tested, thus the multiple-testing adjusted *P*-value cutoff is set at 3.5 × 10^-4^. The correlation between four SNP-methylation-probe pairs reached this experiment-wide significance threshold, suggesting that these JIA SNPs may regulate the expression of their target genes through DNA methylation ([Table 1](#T1){ref-type="table"}).

Discussion
==========

In this study, we conducted data mining in existing datasets to gain a better understanding of the molecular mechanism of JIA GWAS loci. By eQTL and transcriptome analyses, we identified 11 genes may be JIA loci target genes in neutrophils. We further built PPI network and found pathways enriched among target genes and their interactors. We also found multiple JIA GWAS SNPs overlap with histone marks and/or correlate with methylation level in their target genes.

We did not observe extensive overlap between JIA eQTL genes in whole blood and genes of differential expression in neutrophils. It possibly resulted from the small sample size in our microarray datasets which did not have enough power to detect certain differentially expressed genes. In addition, JIA eQTL genes may be expressed in cell types other than neutrophils which we are particularly interested in.

Several of the target genes we identified are highly related to the immune system, such as *CCR3*, *ELL2*, and *HLA-DPA1*. Others play a role in cell proliferation, carcinogenesis and/or other biological functions. The Human leukocyte antigen (HLA) gene complex encodes human major histocompatibility complex (MHC), a group of cell-surface proteins playing important roles in the regulation of human immune system. *HLA* genes have been reported to be associated with autoimmune diseases ([@B53]; [@B28]), including rheumatoid arthritis ([@B41]; [@B52]) and JIA ([@B51]). The *HLA-DPA1* locus has been particularly linked to ankylosing spondylitis, a type of chronic inflammatory rheumatic disease ([@B9]). As expected, *HLA* genes were also found as target genes in PBMC, suggesting they contribute to pathogenesis of JIA in diverse immune cell types. *CCR3* gene encodes a protein as a member of the G protein-coupled receptor family, responding to the C-C type chemokines. SNP in *CCR3-CCR5* region has been linked to family history of autoimmune disease among children with type I diabetes ([@B43]). It has been reported that *CCR3* expression was increased under rheumatoid arthritis conditions, and it mediated eotaxin-1 induced matrix metalloproteinase (MMP)-9 upregulation in fibroblast-like synoviocyte which may further result in articular damage ([@B33]). Previous studies have also demonstrated that CCR3 is highly expressed in infiltrated synovial neutrophils of rheumatoid arthritis patients ([@B20]). *ELL2* gene encodes Elongation Factor for RNA Polymerase II 2, a component of the super-elongation complex. It functions in immune regulation by affecting IgH alternative processing, Ig secretion and plasma cell differentiation. Missense mutation in *ELL2* gene affects IgA and IgG level associated with multiple myeloma ([@B55]). Study has shown that ELL2 is expressed in mature neutrophils and its expression is elevated in responses to inflammatory stimuli ([@B63]). Our results suggest that these genes may also play a role in neutrophils mediating the effect of JIA risk loci during JIA pathogenesis which should be further investigated by experimental approaches.

The pathways of cardiac muscle contraction and hypertrophic cardiomyopathy are significantly and specifically enriched in PPI network of JIA target genes and their interactors in neutrophils. Multiple studies have reported that patients with rheumatoid arthritis have a higher incidence and mortality of cardiovascular disease ([@B36]; [@B58]; [@B1]; [@B16]). Cardiac involvement has similarly been found in JIA patients ([@B54]; [@B24]). However, whether JIA increases the long-term risk of cardiovascular disease is still uncertain ([@B8]). Our results suggest that JIA and cardiovascular disease may share common underlying molecular mechanism.

High-throughput omics technology provides a wealth of experimental data for disease gene discovery. The multi-omics studies on the interplay between genes, RNA, proteins and small molecules reveal new directions for the research of complex diseases ([@B5]; [@B6]). Integration of data from different dimensions of multi-omics data via different analytical approaches facilitates prioritizing genes for efficient functional studies and contributes to the understanding of disease etiology.
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